Literature DB >> 21609321

Function of MRP1/ABCC1 is not dependent on cholesterol or cholesterol-stabilized lipid rafts.

Peter Meszaros1, Karin Klappe, Ina Hummel, Dick Hoekstra, Jan Willem Kok.   

Abstract

MRP1 (multidrug-resistance-related protein 1)/ABCC1 (ATP-binding cassette transporter C1) has been localized in cholesterol-enriched lipid rafts, which suggests a role for these lipid rafts and/or cholesterol in MRP1 function. In the present study, we have shown for the first time that nearly complete oxidation of free cholesterol in the plasma membrane of BHK-MRP1 (MRP1-expressing baby hamster kidney) cells did not affect MRP1 localization in lipid rafts or its efflux function, using 5-carboxyfluorescein diacetate as a substrate. Inhibition of cholesterol biosynthesis, using lovastatin in combination with RO 48-8071, an inhibitor of oxidosqualene cyclase, resulted in a shift of MRP1 out of lipid raft fractions, but did not affect MRP1-mediated efflux in Neuro-2a (neuroblastoma) cells. Short-term methyl-β-cyclodextrin treatment was equally effective in removing free cholesterol from Neuro-2a and BHK-MRP1 cells, but affected MRP1 function only in the latter. The kinetics of loss of both MRP1 efflux function and lipid raft association during long-term methyl-β-cyclodextrin treatment did not match the kinetics of free cholesterol removal in both cell lines. Moreover, MRP1 activity was measured in vesicles consisting of membranes isolated from BHK-MRP1 cells using the substrate cysteinyl leukotriene C4 and was not changed when the free cholesterol level of these membranes was either decreased or increased. In conclusion, MRP1 activity is not correlated with the level of free cholesterol or with localization in cholesterol-dependent lipid rafts. © The Authors Journal compilation
© 2011 Biochemical Society

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21609321     DOI: 10.1042/BJ20110427

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  8 in total

1.  Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney.

Authors:  Cindy Yanfei Li; Abdul Basit; Anshul Gupta; Zsuzsanna Gáborik; Emese Kis; Bhagwat Prasad
Journal:  J Steroid Biochem Mol Biol       Date:  2019-04-05       Impact factor: 4.292

2.  Streamlined duplex live-dead microplate assay for cultured cells.

Authors:  Bruce A Pfeffer; Steven J Fliesler
Journal:  Exp Eye Res       Date:  2017-05-30       Impact factor: 3.467

3.  Long term myriocin treatment increases MRP1 transport activity.

Authors:  Peter Meszaros; Karin Klappe; Annie van Dam; Pavlina T Ivanova; Stephen B Milne; David S Myers; H Alex Brown; Hjalmar Permentier; Dick Hoekstra; Jan W Kok
Journal:  Int J Biochem Cell Biol       Date:  2012-11-23       Impact factor: 5.085

Review 4.  Multidrug resistance: Physiological principles and nanomedical solutions.

Authors:  Sijumon Kunjachan; Błażej Rychlik; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

5.  Isolation of Lipid Rafts by the Detergent-Based and Non-detergent-Based Methods for Localization of GPCRs with Immunoblotting and Laser Scanning Confocal Microscopy.

Authors:  Peter Abdelmaseeh; Andrew C Tiu; Selim Rozyyev; Laureano D Asico; Pedro A Jose; Van Anthony M Villar
Journal:  Methods Mol Biol       Date:  2021

6.  Enzymatic oxidation of cholesterol: properties and functional effects of cholestenone in cell membranes.

Authors:  Maarit Neuvonen; Moutusi Manna; Sini Mokkila; Matti Javanainen; Tomasz Rog; Zheng Liu; Robert Bittman; Ilpo Vattulainen; Elina Ikonen
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

Review 7.  The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis.

Authors:  Stanislav Kotlyarov; Anna Kotlyarova
Journal:  Int J Mol Sci       Date:  2021-06-23       Impact factor: 5.923

8.  Alpha2beta1 Integrin (VLA-2) Protects Activated Human Effector T Cells From Methotrexate-Induced Apoptosis.

Authors:  Amna Abderrazak; Mohammed-Amine El Azreq; Dalila Naci; Paul R Fortin; Fawzi Aoudjit
Journal:  Front Immunol       Date:  2018-10-15       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.